Propranolol Accord 10 mg Norge - norsk - Statens legemiddelverk

propranolol accord 10 mg

accord healthcare b.v. - propranololhydroklorid - tablett, filmdrasjert - 10 mg

Propranolol Accord 40 mg Norge - norsk - Statens legemiddelverk

propranolol accord 40 mg

accord healthcare b.v. - propranololhydroklorid - tablett, filmdrasjert - 40 mg

Propranolol Accord 80 mg Norge - norsk - Statens legemiddelverk

propranolol accord 80 mg

accord healthcare b.v. - propranololhydroklorid - tablett, filmdrasjert - 80 mg

Aubagio Den europeiske union - norsk - EMA (European Medicines Agency)

aubagio

sanofi winthrop industrie - teriflunomide - multippel sklerose - selektive immunosuppressiva - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Fampyra Den europeiske union - norsk - EMA (European Medicines Agency)

fampyra

biogen netherlands b.v.  - fampridine - multippel sklerose - andre nervesystemet narkotika - fampyra angis for forbedring av gåing i voksen pasienter med multippel sklerose innen funksjonshemming (utvidet funksjonshemming status skala 4-7).

Tysabri Den europeiske union - norsk - EMA (European Medicines Agency)

tysabri

biogen netherlands b.v. - natalizumab - multippel sklerose - selektive immunosuppressiva - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 og 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Fampyra 10 mg Norge - norsk - Statens legemiddelverk

fampyra 10 mg

orifarm as - fampridin - depottablett - 10 mg

Mitoxantron Ebewe 2 mg/ ml Norge - norsk - Statens legemiddelverk

mitoxantron ebewe 2 mg/ ml

ebewe pharma ges.m.b.h nfg. kg - mitoksantronhydroklorid - konsentrat til infusjonsvæske, oppløsning - 2 mg/ ml

Novantrone 2 mg/ ml Norge - norsk - Statens legemiddelverk

novantrone 2 mg/ ml

viatris as - mitoksantronhydroklorid - konsentrat til infusjonsvæske, oppløsning - 2 mg/ ml

Fampridine Accord Den europeiske union - norsk - EMA (European Medicines Agency)

fampridine accord

accord healthcare s.l.u. - fampridine - multippel sklerose - andre nervesystemet narkotika - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).